Due to low demand, about 50 million doses of Covaxin, a COVID-19 vaccine produced by Bharat Biotech, are expected to run out early in the following year. Despite having planned for production to achieve a yearly capacity of 1 billion doses by the end of 2021, Bharat Biotech, halted manufacturing the two-dose immunization Covaxin earlier […]
Continue Reading
The US Food and Drug Administration (FDA) has approved Novavax Inc.’s COVID-19 vaccine as a booster dose for adults to tackle the rapid spread of the COVID-19 virus in the country. The approval from the US FDA is set to reverse Novavax’s shares reverse course, and increase by more than 3 percent. This approval is […]
Continue Reading
The US Food and Drug Administration (FDA) has authorized updated COVID-19 booster vaccine shots developed by Moderna and Pfizer/BioNTech, for children aged five years and above to enhance protection against the COVID-19 virus. The US FDA has updated the emergency use authorizations for the Modern COVID-19 vaccine, and the Pfizer/BioNTech COVID-19 vaccine, bivalent to approve […]
Continue Reading
The European Medicine Agency’s human medicine committee (CHMP) has adopted a positive opinion for Dengue Tetravalent Vaccine, which is used to prevent disease caused by dengue virus serotypes 1, 2, 3, and 4 in people from 4 years of age. Dengue is a mosquito-borne disease caused by four types of the dengue virus that leads […]
Continue Reading
The UK Health Security Agency announced that people at high risk of contracting monkeypox disease will be offered second doses of the vaccine. UKSHA said sexual health clinics will continue to prioritise offering first doses of the monkeypox vaccine to those at high risk. Some clinics will offer a second dose to the eligible people, […]
Continue Reading
Pfizer and its German partner BioNTech are asking the US Food and Drug Administration (FDA) to approve the new COVID-19 booster vaccine shots targeting the Omicron variant for school-age children. Pfizer and BioNTech submitted an application for emergency use authorization of their BA.4 and BA.5 focused bivalent vaccines for children between 5 to 11 years […]
Continue Reading
The Health Sciences Authority (HSA) of Singapore has granted interim authorisation for the use of Spikevax bivalent COVID-19 vaccine by Moderna, which targets both the original Sars-CoV-2 strain, and the Omicron BA.1 variant. The bivalent COVID-19 vaccine is authorized for use as a booster for people aged 18 years and above who have already received […]
Continue Reading
Dr. Rochelle Walensky, director of US Centers for Disease Control and Prevention (CDC), said that very few people who have gotten monkeypox shots in the United States have received the second dose needed for complete protection. Dr. Rochelle Walensky said that around 97 percent of the monkeypox shots were first doses, and many people are […]
Continue Reading
The US Food and Drug Administration (FDA) is expected to approve new COVID-19 booster vaccine shots for the newer Omicron variants this week, making them accessible to people in the United States before any of the human testing is completed. The updated COVID-19 vaccines have been modified to target and focus on the most recent […]
Continue Reading
The US Centers for Disease Control and Prevention (CDC) has signed off on the use of COVID-19 vaccine by Novavax Inc. for adolescents aged 12 to 17 years. The recommendation also follows the authorization of the US Food and Drug Administration (FDA) for the COVID-19 vaccine for the age group. The Novavax vaccine has received […]
Continue Reading